-Voyager Therapeutics - TRACER Capsids Demonstrate Enhanced CNS Transduction Across Species, New Preclinical Results Bolster GBA1, Tau, SOD1 ALS Gene Therapy Programs

Media coverage

• Title	-Voyager Therapeutics - TRACER Capsids Demonstrate Enhanced CNS Transduction Across Species, New Preclinical Results Bolster GBA1, Tau, SOD1 ALS Gene Therapy Programs
  Media name/outlet	M2 PressWIRE
  Country/Territory	United States
  Date	20/05/22
  Persons	Mathieu Nonnenmacher

• Title	Voyager’s TRACER capsids demonstrate enhanced CNS transduction across species; new preclinical results bolster GBA1, Tau, SOD1 ALS gene therapy programmes
  Media name/outlet	PharmaBiz
  Country/Territory	India
  Date	20/05/22
  URL	www.pharmabiz.com/NewsDetails.aspx?aid=150874&sid=2
  Persons	Mathieu Nonnenmacher

• Title	-Voyager Therapeutics - TRACER Capsids Demonstrate Enhanced CNS Transduction Across Species, New Preclinical Results Bolster GBA1, Tau, SOD1 ALS Gene Therapy Programs
  Media name/outlet	ENP Newswire
  Country/Territory	United Kingdom
  Date	20/05/22
  Persons	Mathieu Nonnenmacher